My recommendation anyway.
It'll easily hit that before it goes to $5 again.
Please read the SEC filing on the new CFO. For his incentives to go into effect he is supposed to raise $15 million within 6 months with a share price of AT LEAST $5.
So, for that to happen it needs to drop more so that fresh buyers can be enticed to place small bids on it going thru the roof.
Retail investors like bargins, not new highs to place their bets on.
This company is very likely NOT to create any new drugs, but just spin off hope/greed and do it for a couple years with the prospect of home runs.
And those that think I'm a short seller need to look at the truth. To get to $3.5 it'll be like 100K shares. And again, I can not short at Scotttrade with stocks under $5-- and a lot of brokerages are the same. No real shorts would buy/short this stock for the volume is so tiny any demand at all spikes it. So there is no way they can cover any volume of shares without making the stock rocket. Also, see that short interest is 6% of the outstanding shares. And I think the shorting is the option holders.